Silicon Valley Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Silicon Valley Capital Partners's MRK Position: Q1 2026 in Review
Silicon Valley Capital Partners increased its Merck (MRK) stake by 8.6% in Q1 2026, buying an estimated $3.46K and bringing the position to 380 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #150.
Silicon Valley Capital Partners first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.21M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Silicon Valley Capital Partners held 380 shares of Merck worth $45.8K as of Q1 2026.
- Silicon Valley Capital Partners bought 30 Merck shares in Q1 2026, an estimated $3.46K.
- Merck made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #150 holding.
- Silicon Valley Capital Partners first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
- Silicon Valley Capital Partners's Merck position peaked at $8.21M in Q3 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.